Beta Therapeutics Pty Ltd has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD, QUANTICEL PHARMACEUTICALS INC and DAHL RUSSELL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Israel | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Schwartz Brett | 13 |
#2 | Nelms Keats | 13 |
#3 | Banwell Martin | 10 |
#4 | Jackson Colin | 10 |
#5 | Hammond Edward | 10 |
#6 | Natoli Riccardo | 3 |
#7 | Brett Schwartz | 2 |
#8 | Keats Nelms | 2 |
#9 | Martin Banwell | 2 |
#10 | Edward Hammond | 2 |
Publication | Filing date | Title |
---|---|---|
CA3046997A1 | Heparanase inhibitors and use thereof | |
AU2017376818A1 | Heparanase inhibitors and use thereof | |
US2019345143A1 | Heparanase inhibitors and use thereof | |
EP3554505A1 | Methods of treating ocular disorders |